Company Quick10K Filing
Ocean Bio Chem
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-30
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-01
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-05-13 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-30
8-K 2020-05-15 Earnings, Exhibits
8-K 2020-04-27 Other Events, Exhibits
8-K 2020-04-27 Enter Agreement, Leave Agreement, Off-BS Arrangement, Exhibits
8-K 2020-03-19 Other Events, Exhibits
8-K 2020-01-28 Other Events, Exhibits
8-K 2019-11-14 Earnings, Exhibits
8-K 2019-08-14 Earnings, Exhibits
8-K 2019-06-03 Shareholder Vote
8-K 2019-03-22 Other Events
8-K 2018-11-14 Earnings, Exhibits
8-K 2018-08-31 Enter Agreement, Off-BS Arrangement
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-08-06 M&A, Exhibits
8-K 2018-05-18 Shareholder Vote
8-K 2018-05-15 Earnings, Exhibits
8-K 2018-04-26 Accountant, Exhibits
8-K 2018-03-30 Earnings, Exhibits
8-K 2018-03-19 Other Events
8-K 2018-01-17 Earnings, Exhibits

Ocean Bio Chem Financials

OBCI Metrics, Comps, Filings

Quarterly | Annual

Business

We are principally engaged in the manufacture, marketing and distribution of a broad line of appearance, performance and maintenance products for the marine, automotive, power sports, recreational vehicle and outdoor power equipment markets, under the Star brite® and Star Tron® brand names. We sell these products within the United States of America and Canada. In addition, we produce private label formulations of many of our products for various customers and provide custom blending and packaging services for these and other products. We also manufacture, market and distribute chlorine dioxide-based deodorizing disinfectant, and sanitizing products under the Star brite® and Performacide® brand names, utilizing a patented delivery system for use with products containing chlorine dioxide. Unless the context indicates otherwise, we sometimes refer to Ocean Bio-Chem, Inc. and its consolidated subsidiaries as “the Company,” “we” or “our.”

Ocean Bio-Chem, Inc. was incorporated in 1973 under the laws of the state of Florida. In 1981, we purchased, from Peter G. Dornau and Arthur Spector, the co-founders of the Company, rights to the Star brite® trademark and related products for the United States and Canada. Mr. Dornau, our Chairman, President and Chief Executive Officer, has retained rights to these assets with respect to all other geographic areas. Accordingly, products we manufacture that are sold outside of the United States and Canada are purchased from us and distributed by two companies owned by Mr. Dornau. Net sales to the two companies in 2018 and 2017 totaled approximately $2,190,000 and $2,070,000 or 5.2% and 5.5% of our net sales, respectively. See Note 10 to the consolidated financial statements included in this report for additional information.

Because our operations involve, in all material respects, substantially similar manufacturing and distribution processes, our operations constitute one reportable segment for financial reporting purposes.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nexeo Solutions (NXEO) 757,054 11% 9.1 1% 2,179,100 1,359,600 4,040,400 451,900 19,100 169,200 1,533,454
Innophos Holdings (IPHS) 681,397 18% 20.0 2% 875,844 537,946 758,544 135,019 21,366 49,446 990,666
Hawkins (HWKN) 452,894 18% 9.4 7% 393,042 163,607 548,581 98,498 26,958 55,485 523,838
OMNOVA Solutions (OMN) 253,536 23% 10.7 1% 583,900 524,200 759,500 178,300 6,000 50,400 539,836
Foamix Pharmaceuticals (FOMX) 187,642 74% -2.8 -70% 81,583 28,054 1,168 860 -57,358 -57,278 159,797
MediWound (MDWD) 118,500 0% 35,276 0 0 0 0 118,411
Natural Alternatives International (NAII) 59,541 16% 4.0 4% 115,237 37,832 130,953 20,796 4,078 7,694 31,041
Mannatech (MTEX) 39,837 80% 1.4 2% 66,806 42,161 118,340 95,087 1,185 5,740 8,031
China Jo-Jo Drugstores (CJJD) 39,524 24% -45.8 -3% 87,150 65,526 111,004 26,449 -2,744 -481 22,025
Ocean Bio Chem (OBCI) 30,878 38% 8.3 7% 39,134 9,050 32,529 12,344 2,849 3,758 31,094
Cyanotech (CYAN) 18,636 41% 31.4 -3% 32,437 17,093 31,864 13,083 -1,090 788 24,748
CTI Industries (CTIB) 8,286 16% -2.5 -16% 32,897 30,950 33,481 5,342 -5,142 -3,674 9,028
Fuwei Films (FFHL) 6,793 14% 4.5 -2% 454,682 257,851 303,573 42,152 -8,960 -8,960 -40,115
Chromadex (CDXC) 249 55% 0.4 -54% 43,139 15,997 33,202 18,304 -23,294 -21,662 -8,507
HEXO (HEXO)
Aphria (APHA)
Canopy Growth Corporation (CGC)
Cronos Group (CRON)
Aurora Cannabis (ACB)
Happiness Biotech (HAPP) 0% 65,679 4,763 0 0 0 0 -14,801

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash5398095856851,1287751,5085341,0066793,0722,8302,7141,8283,0632,0122,8479332,4682,4361,7961,0864,0703,3998683,4342,7475,0503,6884,3983,7342,7273,2873,986
Accounts Receivable3,5105,4872,5633,0512,9645,9122,9313,2063,8686,8814,4142,9684,2176,1544,8503,4824,0127,6075,0924,0905,5669,4144,9324,7796,2488,4544,9645,0039,07210,7925,6596,6938,55410,254
Inventory9,18410,6609,6289,9359,1459,5359,25710,0879,6908,5987,3688,7647,9508,7948,10910,0979,1059,3777,9159,0668,8008,9558,60110,16610,20910,1249,0749,96810,13411,65312,08612,52511,68311,408
PP&E5,2985,2155,2135,14113,40613,54113,86113,98014,18914,33614,37314,51714,81015,00915,09015,37115,77115,94616,09816,13716,21716,28616,47217,37618,96419,99321,71122,28722,63222,89123,07023,32923,45423,552
Assets20,20623,97419,87920,58120,27923,18821,01021,32121,79723,66822,24322,55922,76424,47623,98024,18524,22925,99723,98924,16324,31127,21025,67127,51727,27834,39931,99132,85735,49340,58335,23536,67037,18939,134
Accounts Payable1,0552,7121,1621,3211,5772,2751,4311,5561,5912,2661,0141,4911,3482,3971,4401,9961,4102,6181,1022,1191,7872,9941,5122,5472,2302,7761,8071,9292,5463,4091,4721,5871,4812,541
Long-Term Debt2,4982,4402,3402,2401,7371,9971,9021,8061,7091,6111,5131,4131,3131,2121,1101,007903798692585478369260149414,1654,0824,0203,9594,6224,5144,4194,3094,202
Liabilities7,59210,2125,8456,1715,1947,3244,5804,5604,5535,7093,9714,4513,9134,9493,9484,1774,1055,4213,3454,5774,0715,1453,1564,4993,8399,8227,0957,9979,49713,0247,8018,9748,4699,050
Stockholders' Equity12,30713,46513,75114,13914,82215,61016,17616,52817,02017,72718,04417,88618,63519,52820,03220,00820,12420,57620,64419,58620,24022,06522,51523,01723,43924,57724,89624,86125,99527,55927,43327,69628,72030,084
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue8,2189,8846,8476,0057,88210,2624906,3128,17810,4417,7735,9218,81310,4328,7616,0028,73910,8378,4106,7508,72412,2075818,3929,90311,6525458,38411,39913,1829,08110,94512,503
Cost of Revenue5,2406,5384,9953,863101010101010101010101010107,274104,3685,0537,307105,2575,6247,5426,0135,4066,7458,6715,6606,4288,097
Gross Profit2,9783,3461,8522,1422,8653,2642,3562,2412,9723,1822,4932,0883,4313,5933,0182,0373,1643,5622,5772,3823,6714,9002,9213,1354,2784,1102,9742,9784,6544,5113,4214,5174,406
R&D1010
SG&A1,6741,2419721,0561,6041,3061,1611,1501,8791,5521,3481,1522,1321,6151,6411,4222,0572,3511,7502,4861,7941,9111,4691,5441,9842,0111,7591,5552,2892,1091,7002,2122,149
Tax22447976386446389140179923511941301684262328753144530346674248236617529125156364358209285319
Net Income3891,138217364363771464349173629318224411903511-1611429667-5416571,5284515049538542935231,1211,2727151,0101,125
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-3972,524-4101,758-1,4112,838-752784-2982,832-3717-4231,495-6051,246-1,6251,78513896-4973,289363-245522-1,498-180-6068651,329
Cash Investing-70-159-90-139-145-396-119-209-307-37-183-293-349-155-316-306-180-152-76-81-101-186-905-1,629-572-344-641-304-125-98
Cash Financing741-2,591600-1,1731,200-1,708-101-102278-403-40-543-103-104-105-110-112-111-91-653-113-121-117-664-664801,530-98-180-533